CryoPort (NASDAQ:CYRX) Insider Edward Zecchini Sells 1,400 Shares

by · The Cerbat Gem

CryoPort, Inc. (NASDAQ:CYRX – Get Free Report) insider Edward Zecchini sold 1,400 shares of the company’s stock in a transaction on Wednesday, June 10th. The shares were sold at an average price of $15.23, for a total transaction of $21,322.00. Following the completion of the transaction, the insider owned 109,719 shares of the company’s stock, valued at $1,671,020.37. This represents a 1.26% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

CryoPort Stock Performance

NASDAQ CYRX traded up $0.24 during trading hours on Friday, hitting $14.62. The company had a trading volume of 502,102 shares, compared to its average volume of 554,117. CryoPort, Inc. has a 1-year low of $6.16 and a 1-year high of $16.73. The company has a market cap of $736.85 million, a PE ratio of 10.83 and a beta of 1.90. The business has a 50 day moving average of $12.30 and a 200-day moving average of $10.30.

CryoPort (NASDAQ:CYRX – Get Free Report) last released its quarterly earnings data on Monday, May 4th. The company reported ($0.23) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by ($0.03). CryoPort had a net margin of 41.57% and a negative return on equity of 7.92%. The company had revenue of $47.80 million during the quarter, compared to analyst estimates of $44.86 million. Sell-side analysts expect that CryoPort, Inc. will post -0.85 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in CYRX. Basepoint Wealth LLC acquired a new position in CryoPort in the 4th quarter valued at about $34,000. Tower Research Capital LLC TRC raised its stake in CryoPort by 300.1% in the 2nd quarter. Tower Research Capital LLC TRC now owns 5,833 shares of the company’s stock valued at $44,000 after purchasing an additional 4,375 shares during the last quarter. AlphaQuest LLC acquired a new position in CryoPort in the 3rd quarter valued at about $79,000. Creative Planning acquired a new position in CryoPort in the 2nd quarter valued at about $96,000. Finally, Quadrature Capital Ltd acquired a new position in CryoPort in the 4th quarter valued at about $97,000. Institutional investors and hedge funds own 92.90% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the stock. KeyCorp raised their price objective on shares of CryoPort from $15.00 to $17.00 and gave the company an “overweight” rating in a research report on Wednesday, May 20th. Craig Hallum increased their target price on shares of CryoPort from $15.00 to $20.00 and gave the company a “buy” rating in a report on Wednesday, June 3rd. BTIG Research increased their target price on shares of CryoPort from $15.00 to $17.00 and gave the company a “buy” rating in a report on Tuesday, May 5th. Wall Street Zen raised shares of CryoPort from a “sell” rating to a “hold” rating in a report on Monday, May 11th. Finally, Weiss Ratings raised shares of CryoPort from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, May 6th. Eight equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $15.11.

Get Our Latest Stock Report on CryoPort

CryoPort Company Profile

(Get Free Report)

CryoPort, Inc (NASDAQ: CYRX) is a global provider of temperature-controlled logistics solutions for the life sciences industry. The company specializes in cryogenic shipping for critical biological materials, supporting the development, clinical testing and commercialization of cell and gene therapies, biologics, vaccines and reproductive medicine. By offering end-to-end supply chain management, CryoPort helps ensure the integrity and viability of temperature-sensitive products from point of origin to destination.

CryoPort’s product portfolio includes proprietary cryogenic dry shippers, advanced active and passive thermal packaging, and real-time data monitoring platforms.

Featured Stories